I received the attached "Dear Doctor" letter yesterday, and upon reading the contents, I must commend GSK on their corporate responsibility in creating a positive effect on our healthcare delivery system in the US. The elimination of sales goals as an incentive compensation measure and new guidelines for how pharmaceutical representatives are compensated and evaluated (effective July 1) is a powerful indication of big-pharma regulating itself and improving its image in the eyes of providers and patients. GO GSK!
No comments:
Post a Comment